Cue Biopharma, Inc. - 8-K Filing

Cue Biopharma's stockholders approved the 2026 Stock Incentive Plan at a special meeting on June 1, 2026. They also approved the issuance of shares upon exercise of warrants from a licensing transaction and related private placement in May 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits Exhibit No)

SEC EDGAR ·

Tickers: $CUE

Read the full article at SEC EDGAR

More Regulatory news